200,000+ products from a single source!

sales@angenechem.com

Home > Pyrazole Based Mono- and Di-Substituted Half Sandwich d6 Platinum Group Metal Complexes: Synthesis and Spectral Characterization

Pyrazole Based Mono- and Di-Substituted Half Sandwich d6 Platinum Group Metal Complexes: Synthesis and Spectral Characterization

 

 

 

Basava Punna Rao Aradhyula,[a] Ibaniewkor L. Mawnai,[a] and Mohan Rao Kollipara

 

1 Introduction
Half-sandwich d6 metal complexes have emerged as versatile intermediates in the organic chemistry synthesis due to the availability of three labile coordinate sites and rigid arene ring occupying another three coordinate sites.[1,2] In these systems the nature of the arene, the chelating ligands, and the leaving group in these complexes strongly influence their chemical and biological activity and exhibit structure–activity relationships.[3]

 

Among the half-sandwich complexes, ruthenium complexes represent one of the most sought-after organometallic compounds due to their potential applications in various areas.[4–7] In recent years arene RuII complexes have attracted more attention in chemotherapy because of their low toxicity and excellent inhibitory activity against tumor cell. Furthermore, many half-sandwich ruthenium complexes with various N-based ligands such as [N, N],[8] [N, O],[9–11] [N, C],[12–14] [N, P],[15,16] [N, S], and [N, Se][17,18] have been synthesized and applied to various organic transformations. Recently, the isoelectronic cyclopentadienyl RhIII and IrIII complexes have also been shown to have highly potent anticancer activity.[19–23]

 

We are currently interested in the coordination chemistry of pyrazole derived ligands because of their unusual structural features and remarkable physical and chemical properties.[24] One of the important structural feature of these pyrazoles is existence of annular tautomerism such phenomenon promotes the pyrazole based ligands to coordinate the metal atoms in a steric free manner.[25,26] Their importance is attributed to their rich electronic property, which can be altered by appropriate choice of substituents on the pyrazole ring, which in turn enables optimization of the electronic properties on the metal.

 

Pyrazole derivatives exhibit broad spectrum of pharmacological activities[27,28] like anti-inflammatory,[29] anticonvulsant,[30] anticancer,[31] and antifungal[32] behavior. Initially Ward et al. have reported many coordination architectures through 3-(2-pyridyl) pyrazole based ligands.[33] Previous studies in this laboratory have reported many halfsandwich ruthenium, rhodium, and iridium complexes with
various pyrazole-based ligands such as pyrazolyl-pyrimidine, pyrazolyl-pyridazine, pyrazolyl-pyridine, thienyl and furyl pyrazole, and pyrazolyl-quinoxaline.[34] In continuation to our previous work, herein we report the synthesis and characterization of a series of mono and bis substituted pyrazole based half-sandwich d6 metal complexes with 5-(4-bromophenyl)-1H-pyrazole ligand. Aryl halides are crucial precursors for the coupling reactions; these bromo-substituted complexes could serve as precursors for the design of metallacycles.


2 Experimental Section
2.1 Materials and Methods
4-Bromoacetophenone, dimethylformamide dimethyl acetal (DMFDMA), and hydrazine hydrate were purchased from Sigma–Aldrich and used as received. All the solvents used for synthesis were dried
and distilled prior to use according to the standard procedures and stored over activated molecular sieves.[35] Starting precursors [(benzene)RuCl2]2, [(p-cymene)RuCl2]2, [Cp*RhCl2]2 and [Cp*IrCl2]2, and ligand (L) were prepared according to the literature methods.[36–41] The elemental analyses were performed with a Perkin–Elmer-2400 CHN analyzer. The electronic absorption spectra of the compounds were recorded with a Perkin–Elmer Lambda 25 absorption spectrophotometer and the solvent used was acetonitrile. IR spectra were recorded with a Perkin–Elmer 983 model FT-IR spectrophotometer with compounds being pressed as KBr discs. All 1 H NMR spectra were recorded with a Bruker Avance II 400 MHz spectrometer at room temperature in CDCl3 and [D6]DMSO; chemical shifts are referenced
to resonances of the deuterated solvents. ESI-MS was carried out with a Bruker micro TOF-Q II using acetonitrile as the solvent.

 

2.2 X-ray Data Collection, Structure Solution, and Refinement
Crystals of complexes 1–8 were grown by slow diffusion of hexane into acetone or dichloromethane (DCM) solutions of the complexes and isolated as orange and pale-yellow blocks. The crystallization was
done at ambient temperature. Suitable single crystals were selected under the microscope and immersed in inert oil to prevent losing solvent molecule (mostly DCM as solvent) from crystals. The crystals
were mounted on a glass capillary and attached to a goniometer head on an Xcalibur, Eos, Gemini diffractometer equipped with graphitemonochromated Mo-Kα radiation (λ = 0.71073 Å). The full data sets
were recorded and the images processed using the Crys Alis Pro.[42]

 

Structure solution by direct methods was achieved through the use of the SHELX program,[43] and the structural model refined by full-matrix least-squares on F2 using SHELX.[44] The non-hydrogen atoms
were refined with anisotropic thermal parameters. Hydrogen atoms were placed using idealized geometric positions (with free rotation for methyl groups), allowed to move in a “riding model” along with the atoms, to which they were attached, and refined isotropically. Molecular graphics were plotted using POVray via ORTEP-3[45] for Windows. ORTEP presentations of the representative complexes are shown in Figure 1, Figure 2, and Figure 3. The data collection and refinement parameters are summarized in Table 1 and Table 2. Bond lengths and angles are listed in Table 3.

 

Crystallographic data (excluding structure factors) for the structures in this paper have been deposited with the Cambridge Crystallographic Data Centre, CCDC, 12 Union Road, Cambridge CB21EZ, UK. Copies of the data can be obtained free of charge on quoting the depository numbers CCDC-1852616 (1), CCDC-1852617 (2), CCDC-1852618 (3), CCDC-1852621 (5), CCDC-1852620 (7), and CCDC-1852622 (8) (Fax: +44-1223-336-033; E-Mail: deposit@ccdc.cam.ac.uk, http://www.ccdc.cam.ac.uk).

 

2.3 General Procedure for the Synthesis of Mononuclear Complexes 1–8
The reaction of precursor [(arene)MCl2]2 complexes (0.08 mmol) with the ligand (L) (0.16 mmol for mono-substituted and 0.32 mmol for disubstituted) in DCM (20 mL) were stirred for 4–6 h. During the course of the reaction, the color of the solution changed from red to orange yellow. The solution was filtered through a bed of celite to remove the undissolved materials and the solvents evaporated. The resulting residue was washed with diethyl ether (210 mL) and the precipitates were air-dried. All the complexes were soluble in polar organic solvents viz., acetone, dichloromethane (DCM), chloroform, acetonitrile but are insoluble in non-polar organic solvents viz., hexane, benzene, and toluene.

 

2.3.1 [(benzene)RuCl2L] (1)
Yield: 47%. IR (KBr): ν˜ = 3434 (νN–H), 1639 (νC=C), 1432 (νC=N) cm–1. 1 H NMR (400 MHz, CDCl3): δ = 12.94 (s, 1 H), 8.26 (d, J = 4 Hz, 1 H), 7.75 (d, J = 8 Hz, 2 H), 7.56 (d, J = 8 Hz, 2 H), 6.69 (d, J = 4 Hz, 2 H), 5.97 (s, 6 H, CH(benzene)). ESI-MS (m/z): 321.26 [M – Cl2-Br]+. UV/Vis {acetonitrile, λmax (nm) (10–4 m–1·cm–1)}: 420, 256.

 

2.3.2 [(p-cymene)RuCl2L] (2)
Yield: 55%. IR (KBr): ν˜ = 3430 (νN–H), 1636 (νC=C), 1460 (νC=N) cm–1. 1 H NMR (400 MHz, CDCl3): δ = 12.01 (s, 1 H,NH), 7.92 (d, J = 4 Hz, 1 H), 7.55 (d, J = 12 Hz, 2 H), 7.36 (d, J = 8 Hz, 2 H), 6.63 (d, J = 4 Hz, 1 H), 5.58 (d, J = 4 Hz, 2 H, CH(p–cym)), 5.41 (d, J = 8 Hz, 2 H, CH(p–cym)), 3.02 (sep, 1 H), 2.30 (s, 3 H, CH(p–cym)), 1.31 (d, J = 8 Hz, 6 H). ESI-MS (m/z): 377.11 [M – Cl2-Br]+. UV/Vis {acetonitrile, λmax (nm) (10–4 m–1·cm–1)}: 408, 256.

 

2.3.3 [Cp*RhCl2L] (3)
Yield: 53%. IR (KBr): ν˜ = 3443 (νN–H), 1625 (νC=C), 1462 (νC=N) cm–1. 1 H NMR (400 MHz, CDCl3): δ = 12.19 (s, 1 H, NH), 8.12 (t, J = 2·Hz, 1 H), 7.96 (d, J = 2 Hz, 2 H), 7.55 (d, J = 8 Hz, 2 H), 6.60 (t, J = 4 Hz, 1 H), 1.70 (s, 15 H, CH(Cp*)). ESI-MS (m/z): 379.21 [M – Cl2-Br]+. UV/Vis {acetonitrile, λmax (nm) (10–4 m–1·cm–1)}: 344, 261.

 

2.3.4 [Cp*IrCl2L] (4)
Yield: 50%. IR (KBr): ν˜ = 3434 (νN–H), 1637 (νC=C), 1467 (νC=N) cm–1. 1 H NMR (400 MHz, CDCl3): δ = 12.34 (s, 1 H, NH), 7.72 (d, J = 4 Hz, 1 H), 7.55 (d, J = 4 Hz, 2 H), 7.50 (d, J = 8 Hz, 2 H), 6.55
(d, J = 4 Hz, 1 H) 1.60 (s, 15 H, CH(Cp*)). ESI-MS (m/z): 469.87 [M –Cl2-Br]+. UV/Vis {acetonitrile, λmax (nm) (10–4 m–1·cm–1)}: 355, 258.

 

2.3.5. [(benzene)RuClL2]Cl (5)
Yield: 45%. IR (KBr): ν˜ = 3434 (νN–H), 1634 (νC=C), 1459 (νC=N) cm–1. 1 H NMR (400 MHz, [D6]DMSO): δ = 12.95 (s, 2 H, NH), 7.75 (d, J = 8 Hz, 4 H), 7.57 (d, J = 8 Hz, 4 H), 7.35 (d, J = 2 Hz, 2 H), 6.73 (d, J = 2 Hz, 2 H), 5.95 (s, 6 H, CH(benzene)). ESI-MS (m/z): 465.05 [M – Cl2-Br]+. UV/Vis {acetonitrile, λmax (nm) (10–4 m–1·cm–1)}: 411, 259.2.3.6.

 

2.3.6 [(p-cymene)RuClL2]Cl (6)
Yield: 54%. IR (KBr): ν˜ = 3444 (νN–H), 1635 (νC=C), 1467 (νC=N) cm–1. 1 H NMR (400 MHz, CDCl3): δ = 14.90 (s, 2 H, NH) 8.11 (d, J = 2 Hz, 2 H), 7.96 (d, J = 8 Hz, 4 H), 7.62 (d, J = 12 Hz, 4 H), 6.55 (d, J = 4 Hz, 2 H, CH(p–cym)), 6.06–6.11(dd, J = 4 Hz, 8 Hz, 2 H, CH(p–cym)), 2.20 (sep, 1 H, CH(p–cym)), 1.80 (s, 3 H, CH(p–cym)), 1.14 (d, J = 8 Hz, 6 H). ESI-MS (m/z): 521.07 [M – Cl2-Br]+. UV/Vis {acetonitrile, λmax (nm) (10–4 m–1·cm–1)}: 410, 258.

 

2.3.7 [Cp*RhClL2]Cl (7)
Yield: 52%. IR (KBr): ν˜ = 3430 (νN–H), 1638 (νC=C), 1458 (νC=N) cm–1. 1 H NMR (400 MHz, CDCl3): δ = 15.14 (s, 2 H,NH), 8.14 (d, J= 2 Hz, 2 H), 7.98 (d, J = 8 Hz, 4 H), 7.61 (d, J = 8 Hz, 4 H) 6.62 (d, J = 4 Hz, 2 H), 1.69 (s, 15 H, CH(Cp*)). ESI-MS (m/z): 524.23 [M –Cl2-Br]+. UV/Vis {acetonitrile, λmax (nm) (10–4 m–1·cm–1)}: 406, 256.

 

2.3.8 [Cp*IrClL2]Cl (8)
Yield: 52%. IR (KBr): ν˜ = 3459 (νN–H), 1634 (νC=C), 1467 (νC=N) cm–1. 1 H NMR (400 MHz, CDCl3): δ = 15.09 (s, 2 H,NH), 8.05 (d, J= 4 Hz, 2 H), 7.87 (d, J = 8 Hz, 4 H), 7.51 (d, J = 8 Hz, 4 H), 6.51 (d, J = 2 Hz, 2 H), 1.55 (s, 15 H, CH(Cp*)). ESI-MS (m/z): 616.97 [M – Cl2-Br]+. UV/Vis {acetonitrile, λmax (nm) (10–4 m–1·cm–1)}: 420, 257. Supporting Information (see footnote on the first page of this article):
Supporting Information contains IR, proton NMR and mass spectral data.

3 Results and Discussion
3.1 Synthesis of the Ligand
3-(4-Bromophenyl)-1H-pyrazole was synthesized by the reaction of appropriate ratio of 4-bromoacetophenone with DMF-DMA and hydrazine hydrate that undergoes tautomerism giving 5-(4-bromophenyl)-1H-pyrazole as represented in Scheme 1. This is confirmed by the absence of NH signal in the 1 H NMR spectrum of the ligand. On complexation, the ligand prefers to bind to the central metal atom through neutral nitrogen N1 rather than nitrogen (N2) having proton in the case of mono substituted complexes. The same is also observed in the case of di-substituted complexes, where the ligand prefers to bind through neutral nitrogen N1. 


3.2 Synthesis of the Complexes
Treatment of d6 configured halo-bridged metal dimers and the pyrazole ligand in 1:2 and 1:4 ratio resulted in the formation of mono- and di-substituted metal complexes (Scheme 2). The complexes were isolated as yellow and yellow orange solids with moderate yields. However the yield of benzene complexes is less due to their insoluble nature of the precursor complex. Mono substituted complexes are isolated as neutral complexes, whereas the di-substituted complexes are obtained as cationic complexes with chloride as a counterion. Complexes 1–8 are stable at room temperature and are soluble in
polar organic solvents but insoluble in nonpolar solvents. The antibacterial activity of the synthesized complexes was studied but these complexes did not show any activity even at higher concentrations of the complexes. At present it is difficult to predict specifically, which type of structure or group will enhance the activity of the complexes but it may be suggested that substituting the bromide group with amino or methoxy groups might enhance the activity of the complexes as reported in the literature.[31] 


3.3 Characterization of the Complexes
3.3.1 IR Spectroscopy
The IR spectra of the complexes show some broad and strong bands in the region 3428 cm–1 to 1426 cm–1. The band at around 3400 cm–1 indicates the presence of N–H groups, which strongly supports that complexation occur through the neutral nitrogen of the pyrazole ring. The sharp bands at 1590 cm–1 and 1440 cm–1 represent the stretching frequencies of C=C and C=N bonds of the complexes.

 

3.3.2 1 H NMR Spectroscopy
The 1 H NMR spectra of the complexes 1–8 show a singlet in the range 12.1–15.14 ppm, which is attributed to the N-H proton signals. The appearance of the N-H signal in all the complexes indicates that the protic nitrogen is not involved in bonding. This is in good agreement with the appearance of NH stretching frequency as revealed from FT-IR spectroscopy. The aromatic proton signals associated with the ligand are observed as doublet in the range 7.35–7.98 ppm, whereas the proton, which is adjacent to the pyrazole nitrogen exhibits a doublet in the range of 7.91–8.14 ppm, which are downfield shift indicating the coordination of the ligand to the metal ion. The benzene proton resonance in complexes 1 and 5 is observed as a singlet at δ = 5.97 and 5.95 ppm, respectively. The aromatic proton signals of the p-cymene ligand in complexes 2 and 6 are observed as two doublets around 5.40–6.11 ppm, one septet around 2.20–3.02 ppm for the methine protons of the isopropyl group and a singlet around 1.80–2.30 ppm for the methyl protons and doublet around 1.13–1.30 ppm for the isopropyl group. In addition, a sharp singlet is observed for the rhodium and iridium complexes around 1.55–1.70 ppm for the methyl protons of the Cp* ligand. Furthermore, the formation of mono and di- substituted complexes is confirmed by the integral ratio of the ligand L with respect to the precursor complexes. In the
case of mono substituted complexes 1–4, the protons resonate with an integral ratio 1:1, whereas in the case of di-substituted complexes 5–8, the protons resonate with an integral ratio 1:2.
Such an integral ratio between the precursor protons and ligand protons clearly indicates the formation of mono- and di-substituted complexes of pyrazole. 


3.3.3 Mass Spectrometry
The mass spectra of the complexes exhibit the characteristic peak as the loss of their halogen atoms unlike the [M]+ ions. Such [M–counterion / terminal halide]+ ions are generally observed in the half sandwich complexes rather than their molecular ion peak. For instance, the m/z values 377.11 (2), 465.05 (5), 521.07 (6), and 616.97 (8) are in corroboration with the expected [M – Cl1/2-Br]2+. [44,45] The appearance of these peaks in the mass spectra clearly indicates the formation of monoand di-substituted metal complexes. The mass spectral values strongly justify the composition and formulation of these complexes. 


3.3.4 UV/Vis Studies
The electronic spectra of the complexes 1–8 along with the corresponding ligand L was recorded in acetonitrile solution at 20 μM concentration and is depicted in Figure 4. The free ligand exhibits a single characteristic band at around 260 nm. All the complexes exhibit a significant change in the intensity of the bands. In addition to the characteristic ligand band, the complexes also exhibit low intense band at around 400 nm. This is attributed to metal-to-ligand charge-transfer band. The appearance of these weak bands is due to the low concentration of the solution or obscured by the high intense ligand bands.[48,50] In order to observe these low intense bands, the high intense bands have been normalized.


3.4 Molecular Structures
Single crystals suitable for X-ray crystallographic analysis were obtained for all the complexes. The crystals were grown by slow solvent diffusion method where they crystallized from DCM/hexane or acetone/hexane solutions. The molecular structures of the complexes presented as ORTEP diagrams are depicted in Figure 1, Figure 2, and Figure 3. The relevant crystallographic parameters for the complexes 1–8 are presented in Table 1 and Table 2. The selected bond lengths and bond angles are listed in Table 3. Most of the complexes (2–6) crystallize in the monoclinic system with a P21/c (complexes 3–6) and P21/n (complex 2) space group. Complexes 7 and 8 crystallize in the orthorhombic system with space group P212121 whereas complex 1 crystallized in the triclinic system with
space group P1¯. Complexes 2–8 contain four molecules in their unit cell, whereas complex 1 contains two molecules in the unit cell. The molecular structure of these complexes featured a regular three legged piano-stool arrangement with metal coordinated by π-bonded arene ring (arene = p-cymene / benzene / Cp*) in a η6/η5 manner forming the stool, while chloride and pyrazole ligands forming the legs and the metal atoms are satisfied by the distorted octahedral arrangement around their vicinity.

 

The bond lengths and bond angles of the complexes are found to be closely related to the other reported half sandwich d6 metal complexes.[50,51] The metal–nitrogen bond lengths is found to be shorter in comparison to the metal to chloride bond lengths of the complexes. In neutral complexes 1–4 the widest bond angle is that between the two chlorine atoms, whereas in the cationic complexes 5–8 it is between the nitrogen atoms of the two-pyrazole ligands, which may arise due to the electronic repulsions of the similar moieties. In addition, the aromatic benzene ring of the pyrazole ligand is deviated from the coplanarity in the complexes. It may also be noted that the angle between the plane of the pyrazole and bromo substituted benzene ring in mono substituted ruthenium complexes (37.23° for
1 and 31.89° for 2) have more deviation in comparison to the higher congeners (15.45° for 3 and 15.83° for 4). When it comes to di-substituted complexes this interplanar angle between the pyrazole and benzene is almost coplanar with their minimal angles (2.71°, for 5, 9.86° for 6, 4.73° for 7, and 5.10° for 8) of one of the ligand.

 

4 Conclusions
We have isolated eight new mono- and di-substituted pyrazole based half sandwich d6 complexes. Complexation occurs on the basis of the equivalents of the ligand and time of the reaction. Ligand ratio tuned the nature of the complex as neutral and ionic behavior. All the complexes were characterized by spectroscopic and crystallographic studies, which revealed that complexes are formed by preferential binding through the neutral nitrogen of the pyrazole ligand rather than the protic nitrogen. In all these complexes deprotonation of the protic nitrogen does not occur unlike the other complexes containing
pyrazole derivatives. These complexes did not show any biological activities such as antibacterial or anti-fungal studies.

Half-sandwich d6 metal complexes have emerged as versatile intermediates in the organic chemistry synthesis due to the availability of three labile coordinate sites:

CAS No. 100944-51-2

Acetic acid, 2-[6-(hydroxymethyl)-2-oxo-3-morpholinylidene]-, methyl ester

Catalog No.:AG0003A8 MDL No.:

MF:C8H11NO5 MW:201.1766

CAS No. 100944-55-6

Acetic acid, 2-[2-oxo-5-(phenylmethyl)-3-morpholinylidene]-, methyl ester

Catalog No.:AG0003A7 MDL No.:MFCD02082368

MF:C14H15NO4 MW:261.2732

CAS No. 100945-19-5

Ethanone, 1-[3,4-bis(acetyloxy)phenyl]-2-chloro-

Catalog No.:AG0003A6 MDL No.:

MF:C12H11ClO5 MW:270.6657

CAS No. 10095-06-4

Imidazo[4,5-d]imidazole-2,5(1H,3H)-dione, tetrahydro-1,3,4,6-tetramethyl-

Catalog No.:AG0003AH MDL No.:MFCD00184215

MF:C8H14N4O2 MW:198.2224

CAS No. 10095-14-4

2-Propenoic acid, 6-hydroxyhexyl ester

Catalog No.:AG0003AG MDL No.:MFCD27964776

MF:C9H16O3 MW:172.2215

CAS No. 10095-20-2

2-Propenoic acid, 2,3-dihydroxypropyl ester

Catalog No.:AG0003AF MDL No.:

MF:C6H10O4 MW:146.1412

CAS No. 10095-21-3

Benzenamine, 4,4'-oxybis[N-(1-methylpropyl)-

Catalog No.:AG0003AE MDL No.:

MF:C20H28N2O MW:312.4491

CAS No. 10095-76-8

α-D-Glucopyranoside, ethenyl

Catalog No.:AG0003AD MDL No.:

MF:C8H14O6 MW:206.1932

CAS No. 10095-79-1

3,5-Cyclooctadien-1-ol

Catalog No.:AG0003AC MDL No.:

MF:C8H12O MW:124.1803

CAS No. 10095-82-6

2,4-Cyclooctadien-1-ol, 1-acetate

Catalog No.:AG0003AB MDL No.:

MF:C10H14O2 MW:166.2170

CAS No. 10095-83-7

6H-Cyclohepta[c]thiophen-6-one

Catalog No.:AG0003AA MDL No.:

MF:C9H6OS MW:162.2083

CAS No. 10095-91-7

Thiophene, 2,5-dichloro-3-(chloromethyl)-

Catalog No.:AG0003A9 MDL No.:MFCD18431770

MF:C5H3Cl3S MW:201.5013

CAS No. 100950-88-7

1H-Fluorene, 9-ethyl-2,3,4,4a,9,9a-hexahydro-

Catalog No.:AG0003B6 MDL No.:

MF:C15H20 MW:200.3193

CAS No. 100950-90-1

Benzene, (1,1,4,4-tetramethyl-2-pentyn-1-yl)-

Catalog No.:AG0003B5 MDL No.:

MF:C15H20 MW:200.3193

CAS No. 1009505-66-1

Alanine, N-[(3-chloro-4-fluorophenyl)sulfonyl]-

Catalog No.:AG0003AK MDL No.:MFCD03618997

MF:C9H9ClFNO4S MW:281.6885

CAS No. 100951-55-1

Propanamide, N-(cyanophenylmethyl)-2-(diethylamino)-

Catalog No.:AG0003B4 MDL No.:

MF:C15H21N3O MW:259.3467

CAS No. 100952-97-4

Naphtho[1,2-b]furan-2(3H)-one, 4,5-dihydro-

Catalog No.:AG0003B3 MDL No.:

MF:C12H10O2 MW:186.2066

CAS No. 100953-16-0

7H-Furo[3,2-g][1]benzopyran-7-one, 5,6-dihydro-9-methoxy-

Catalog No.:AG0003B2 MDL No.:

MF:C12H10O4 MW:218.2054

CAS No. 100953-23-9

Furo[2,3-b]furan-2,5(3H,4H)-dione, dihydro-6a-phenyl-

Catalog No.:AG0003B1 MDL No.:

MF:C12H10O4 MW:218.2054

CAS No. 100953-58-0

Acetamide, N-[5-bromo-4-(4-methoxyphenyl)-2-thiazolyl]-

Catalog No.:AG0003B0 MDL No.:

MF:C12H11BrN2O2S MW:327.1969

CAS No. 100954-03-8

2-Propynoic acid, 3-phenyl-, phenyl ester

Catalog No.:AG0003AZ MDL No.:

MF:C15H10O2 MW:222.2387

CAS No. 100954-32-3

4(3H)-Quinazolinone, 6-bromo-3-(phenylmethyl)-

Catalog No.:AG0003AY MDL No.:

MF:C15H11BrN2O MW:315.1646

CAS No. 100954-50-5

Benzophenone, 4'-bromo-2-hydroxy-, acetate (6CI)

Catalog No.:AG0003AX MDL No.:

MF:C15H13BrO4 MW:337.1653

CAS No. 100955-75-7

Benzo[b]thiophene-2-carboxamide, N-cyclohexyl-

Catalog No.:AG0003AW MDL No.:

MF:C15H17NOS MW:259.3666

CAS No. 100955-81-5

Benzenemethanamine, 3-methoxy-4-(phenylmethoxy)-, hydrochloride (1:1)

Catalog No.:AG0003AV MDL No.:MFCD00195619

MF:C15H18ClNO2 MW:279.7619

CAS No. 100956-22-7

3-Pentenoic acid, 2-(1-aminoethylidene)-5-oxo-5-phenyl-, ethyl ester

Catalog No.:AG0003AU MDL No.:

MF:C15H17NO3 MW:259.3004

CAS No. 1009562-65-5

Pyridine, 2-[5-(chloromethyl)-1,2,4-oxadiazol-3-yl]-3-methyl-

Catalog No.:AG0003AJ MDL No.:MFCD16087762

MF:C9H8ClN3O MW:209.6323

CAS No. 100957-69-5

2-Propenoic acid, 2-cyano-3-[4-(diethylamino)phenyl]-, methyl ester

Catalog No.:AG0003AT MDL No.:

MF:C15H18N2O2 MW:258.3156

CAS No. 100957-76-4

4-Piperidinecarboxylic acid, 1-(1H-indol-3-ylmethyl)-

Catalog No.:AG0003AS MDL No.:MFCD06739714

MF:C15H18N2O2 MW:258.3156

CAS No. 100957-85-5

1H-Pyrazole-5-carboxylic acid, 3-(1,1-dimethylethyl)-1-(phenylmethyl)-

Catalog No.:AG0003AR MDL No.:MFCD02090479

MF:C15H18N2O2 MW:258.3156

CAS No. 100958-73-4

2,7-Benzothiazolediamine

Catalog No.:AG0003AQ MDL No.:MFCD16619219

MF:C7H7N3S MW:165.2156

CAS No. 100958-94-9

Benzoic acid, 3,5-dibromo-2-methyl-

Catalog No.:AG0003AP MDL No.:MFCD09749956

MF:C8H6Br2O2 MW:293.9400

CAS No. 1009582-56-2

Phenol, 2,4-dibromo-6-[[[[(4S,5S)-4,5-dihydro-1-[(4-methylphenyl)sulfonyl]-4,5-diphenyl-1H-imidazol-2-yl]methyl][(1S)-1-phenylethyl]amino]methyl]-

Catalog No.:AG0003AI MDL No.:

MF:C38H35Br2N3O3S MW:773.5758

CAS No. 100959-06-6

2-Hexene, 6-chloro-2-methyl-

Catalog No.:AG0003AO MDL No.:

MF:C7H13Cl MW:132.6311

CAS No. 100959-19-1

Cyclohexanamine, 4-methyl-, hydrochloride (1:1)

Catalog No.:AG0003AN MDL No.:MFCD00051985

MF:C7H16ClN MW:149.6616

CAS No. 100959-22-6

Benzoic acid, 2-bromo-4-nitro-, methyl ester

Catalog No.:AG0003AM MDL No.:MFCD07779271

MF:C8H6BrNO4 MW:260.0415

CAS No. 100959-30-6

Benzaldehyde, 4-(hydroxymethyl)-, oxime

Catalog No.:AG0003AL MDL No.:

MF:C8H9NO2 MW:151.1626

CAS No. 100959-52-2

1H-Indazol-7-amine, 4-chloro-

Catalog No.:AG0003BU MDL No.:MFCD09026964

MF:C7H6ClN3 MW:167.5956

CAS No. 100959-82-8

1,4,6-Cycloheptatriene-1-carboxamide

Catalog No.:AG0003BT MDL No.:

MF:C8H9NO MW:135.1632

CAS No. 100959-83-9

Bicyclo[4.1.0]hepta-2,4-diene-7-carboxamide

Catalog No.:AG0003BS MDL No.:

MF:C8H9NO MW:135.1632

CAS No. 100959-91-9

4-Oxazolecarboxamide, 2-methyl-

Catalog No.:AG0003BR MDL No.:MFCD00221183

MF:C5H6N2O2 MW:126.1133

CAS No. 100959-93-1

4(3H)-Pyrimidinone, 6-(hydroxymethyl)-

Catalog No.:AG0003BQ MDL No.:

MF:C5H6N2O2 MW:126.1133

CAS No. 1009595-18-9

Valine, N-[(2,3,5,6-tetramethylphenyl)sulfonyl]-

Catalog No.:AG0003BA MDL No.:MFCD05148303

MF:C15H23NO4S MW:313.4124

CAS No. 10096-64-7

Morpholinium, 4-ethyl-4-octadecyl-, ethyl sulfate (1:1)

Catalog No.:AG0003BV MDL No.:

MF:C52H108N2O6S MW:889.4887

CAS No. 100960-02-9

Benzenethiol, 2-methyl-5-nitro-

Catalog No.:AG0003BP MDL No.:

MF:C7H7NO2S MW:169.2010

CAS No. 100960-07-4

5-Amino-7-azaindole

Catalog No.:AG0003BO MDL No.:MFCD06659683

MF:C7H7N3 MW:133.1506

CAS No. 100960-08-5

1H-Pyrrolo[2,3-b]pyridin-3-amine, hydrochloride (1:2)

Catalog No.:AG0003BN MDL No.:MFCD11035725

MF:C7H9Cl2N3 MW:206.0725

CAS No. 100960-11-0

Boronic acid, B-(2-methyl-5-nitrophenyl)-

Catalog No.:AG0003BM MDL No.:MFCD00757435

MF:C7H8BNO4 MW:180.9537

CAS No. 100960-16-5

2-Thiazolecarboxylic acid, 4-(chloromethyl)-, ethyl ester

Catalog No.:AG0003BL MDL No.:MFCD10697515

MF:C7H8ClNO2S MW:205.6619

CAS No. 100960-20-1

9H-Purin-6-amine, 2-chloro-N,N-dimethyl-

Catalog No.:AG0003BK MDL No.:

MF:C7H8ClN5 MW:197.6249

CAS No. 100960-35-8

1H-Indazol-6-amine, 5-chloro-

Catalog No.:AG0003BJ MDL No.:MFCD11846310

MF:C7H6ClN3 MW:167.5956

CAS No. 100960-56-3

3,4-Pyridinedicarbonitrile, 1,2-dihydro-6-methyl-2-oxo-

Catalog No.:AG0003BI MDL No.:

MF:C8H5N3O MW:159.1448

CAS No. 100960-68-7

Benzonitrile, 4-chloro-2-methoxy-

Catalog No.:AG0003BH MDL No.:MFCD09865166

MF:C8H6ClNO MW:167.5923

CAS No. 100960-69-8

Hexanoic acid, 2-bromo-2-methyl-

Catalog No.:AG0003BG MDL No.:

MF:C7H13BrO2 MW:209.0809

CAS No. 100960-85-8

1,3,6-Cycloheptatriene-1-carboxamide

Catalog No.:AG0003BF MDL No.:

MF:C8H9NO MW:135.1632

CAS No. 100960-88-1

Bicyclo[4.1.0]hepta-2,4-diene-2-carboxamide

Catalog No.:AG0003BE MDL No.:

MF:C8H9NO MW:135.1632

CAS No. 100960-95-0

1H-Pyrrole-3-carboxylic acid, 4-acetyl-5-methyl-

Catalog No.:AG0003BD MDL No.:

MF:C8H9NO3 MW:167.1620

CAS No. 100960-98-3

4-Octene, 1,8-dibromo-

Catalog No.:AG0003BC MDL No.:

MF:C8H14Br2 MW:270.0048

CAS No. 1009601-79-9

Pyrazolo[1,5-a]pyridine-4-carboxylic acid, 7-methoxy-2-(1-methylethyl)-

Catalog No.:AG0003B9 MDL No.:

MF:C12H14N2O3 MW:234.2512

CAS No. 1009601-94-8

Pyrazolo[1,5-a]pyridine-4-carboxylic acid, 7-methoxy-

Catalog No.:AG0003B8 MDL No.:MFCD20646139

MF:C9H8N2O3 MW:192.1714

CAS No. 1009602-42-9

Pyrazolo[1,5-a]pyridine-4-carboxylic acid, 7-methoxy-2-(methoxymethyl)-

Catalog No.:AG0003B7 MDL No.:

MF:C11H12N2O4 MW:236.2240

CAS No. 100961-52-2

Benzoic acid, 2-[[(4-cyanophenyl)methyl]thio]-

Catalog No.:AG0003BB MDL No.:MFCD02755584

MF:C15H11NO2S MW:269.3183

CAS No. 100961-61-3

Benzoic acid, 2-[(2-benzothiazolylthio)methyl]-

Catalog No.:AG0003CD MDL No.:MFCD04614082

MF:C15H11NO2S2 MW:301.3833

CAS No. 100961-94-2

Quinazoline, 2-[2-(3-pyridinyl)ethenyl]-

Catalog No.:AG0003CC MDL No.:

MF:C15H11N3 MW:233.2679

CAS No. 100962-02-5

Benzoic acid, 4-(2-quinoxalinylamino)-

Catalog No.:AG0003CB MDL No.:MFCD00139085

MF:C15H11N3O2 MW:265.2667

CAS No. 100962-39-8

1-Piperidineacetamide, N-heptyl-

Catalog No.:AG0003CA MDL No.:

MF:C14H28N2O MW:240.3849

CAS No. 1009620-97-6

1,2,4-Oxadiazole-3-carboxylic acid, 5-(chloromethyl)-, ethyl ester

Catalog No.:AG0003BY MDL No.:MFCD11052346

MF:C6H7ClN2O3 MW:190.5844

CAS No. 100963-26-6

Dodecane, 2-bromo-1,1-dimethoxy-

Catalog No.:AG0003C9 MDL No.:

MF:C14H29BrO2 MW:309.2829

CAS No. 100963-92-6

Phenol, 4-(methoxymethyl)-2,6-bis(1-methylethyl)-

Catalog No.:AG0003C8 MDL No.:

MF:C14H22O2 MW:222.3233

CAS No. 100965-13-7

1H-Imidazole, 4,5-bis(4-bromophenyl)-

Catalog No.:AG0003C7 MDL No.:

MF:C15H10Br2N2 MW:378.0613

CAS No. 100965-76-2

Imidazo[1,2-a]pyridine, 2-(2-benzofuranyl)-

Catalog No.:AG0003C6 MDL No.:

MF:C15H10N2O MW:234.2527

CAS No. 1009662-98-9

Imidazo[1,2-a]pyrimidine-6-carboxylic acid, 7-(trifluoromethyl)-, ethyl ester

Catalog No.:AG0003BX MDL No.:

MF:C10H8F3N3O2 MW:259.1846

CAS No. 10097-02-6

Butanoic acid, 2,2-bis(hydroxymethyl)-

Catalog No.:AG0003CH MDL No.:MFCD00190088

MF:C6H12O4 MW:148.1571

CAS No. 10097-07-1

Glycine, N,N'-1,4-phenylenebis-

Catalog No.:AG0003CG MDL No.:

MF:C10H12N2O4 MW:224.2133

CAS No. 10097-26-4

2-Propenoic acid, 2-methyl-, 2-butyloctyl ester

Catalog No.:AG0003CF MDL No.:

MF:C16H30O2 MW:254.4082

CAS No. 10097-28-6

Silylene, oxo-

Catalog No.:AG0003CE MDL No.:MFCD00151536

MF:OSi MW:44.0849

CAS No. 100970-28-3

Benzene, 1,1'-(dimethoxymethylene)bis[4-nitro-

Catalog No.:AG0003C5 MDL No.:

MF:C15H14N2O6 MW:318.2815

CAS No. 100971-82-2

1-Butanone, 1,1'-(1,4-phenylene)bis-

Catalog No.:AG0003C4 MDL No.:

MF:C14H18O2 MW:218.2915

CAS No. 100971-92-4

1H-Indene-5-carboxylic acid, 2,3-dihydro-1,1,3,3-tetramethyl-

Catalog No.:AG0003C3 MDL No.:

MF:C14H18O2 MW:218.2915

CAS No. 100972-06-3

2H-Thiopyran-4-carboxylic acid, tetrahydro-4-phenyl-, ethyl ester

Catalog No.:AG0003C2 MDL No.:

MF:C14H18O2S MW:250.3565

CAS No. 100972-13-2

Benzenepentanoic acid, 2-methyl-δ-oxo-, ethyl ester

Catalog No.:AG0003C1 MDL No.:MFCD01320209

MF:C14H18O3 MW:234.2909

CAS No. 100972-86-9

Propanedioic acid, 2-(2-methylphenoxy)-, 1,3-diethyl ester

Catalog No.:AG0003C0 MDL No.:

MF:C14H18O5 MW:266.2897

CAS No. 1009722-72-8

Pyrazino[2,1-c][1,4]benzodiazepine-6,12(2H,11H)-dione, 8-bromo-1,3,4,12a-tetrahydro-

Catalog No.:AG0003BW MDL No.:

MF:C12H12BrN3O2 MW:310.1466

CAS No. 100973-01-1

1,2-Benzenedicarboxylic acid, 3,4-dimethoxy-, 1,2-diethyl ester

Catalog No.:AG0003BZ MDL No.:

MF:C14H18O6 MW:282.2891

CAS No. 100973-67-9

5-Pyrimidinecarboxylic acid, 2-(methylthio)-4-[(phenylmethyl)amino]-, ethyl ester

Catalog No.:AG0003D3 MDL No.:

MF:C15H17N3O2S MW:303.3794

CAS No. 1009734-33-1

2,4-Quinazolinediamine, 5-(1,1-dimethylethoxy)-

Catalog No.:AG0003CS MDL No.:MFCD22666183

MF:C12H16N4O MW:232.2816

CAS No. 1009735-22-1

3-Pyridinecarboxylic acid, 2,6-dibromo-, methyl ester

Catalog No.:AG0003CR MDL No.:MFCD14698025

MF:C7H5Br2NO2 MW:294.9281

CAS No. 1009735-23-2

3-Pyridinecarboxylic acid, 2-bromo-6-methoxy-, methyl ester

Catalog No.:AG0003CQ MDL No.:MFCD18257522

MF:C8H8BrNO3 MW:246.0580

CAS No. 1009735-24-3

3-Pyridinecarboxylic acid, 6-bromo-2-methoxy-, methyl ester

Catalog No.:AG0003CP MDL No.:

MF:C8H8BrNO3 MW:246.0580

CAS No. 1009735-25-4

3-Pyridinecarboxylic acid, 2-bromo-6-methoxy-

Catalog No.:AG0003CO MDL No.:

MF:C7H6BrNO3 MW:232.0314

CAS No. 100976-32-7

2H-1-Benzopyran-3-carboxylic acid, 2-oxo-4-propyl-, ethyl ester

Catalog No.:AG0003D2 MDL No.:

MF:C15H16O4 MW:260.2851

CAS No. 100976-54-3

1,2-Benzenediol, 4,4'-(1,3-propanediyl)bis-

Catalog No.:AG0003D1 MDL No.:

MF:C15H16O4 MW:260.2851

CAS No. 100976-74-7

2-Naphthalenebutanoic acid, 1,2,3,4-tetrahydro-6-methoxy-γ,1-dioxo-

Catalog No.:AG0003D0 MDL No.:

MF:C15H16O5 MW:276.2845

CAS No. 100978-95-8

2-Propenamide, N,3-diphenyl-N-(phenylmethyl)-

Catalog No.:AG0003CZ MDL No.:

MF:C22H19NO MW:313.3924

CAS No. 10098-07-4

Benzoic acid, 4-[[(4-methylphenyl)sulfonyl][3-(2-oxiranyl)propyl]amino]-, ethyl ester

Catalog No.:AG0003D7 MDL No.:

MF:C21H25NO5S MW:403.4919

CAS No. 10098-39-2

Benzeneacetic acid, α-hydroxy-4-nitro-

Catalog No.:AG0003D6 MDL No.:

MF:C8H7NO5 MW:197.1449

CAS No. 10098-40-5

Benzoic acid, 4-(acetylamino)-3-hydroxy-

Catalog No.:AG0003D5 MDL No.:MFCD00869774

MF:C9H9NO4 MW:195.1721

CAS No. 10098-89-2

L-Lysine, hydrochloride (1:?)

Catalog No.:AG0003D4 MDL No.:MFCD00064564

MF:C6H15ClN2O2 MW:182.6485

CAS No. 100980-74-3

Benzoic acid, 4-[[(octyloxy)carbonyl]oxy]-

Catalog No.:AG0003CY MDL No.:

MF:C16H22O5 MW:294.3429

CAS No. 100980-82-3

[1,1'-Biphenyl]-4-carboxaldehyde, 4'-hydroxy-

Catalog No.:AG0003CX MDL No.:MFCD00804656

MF:C13H10O2 MW:198.2173

CAS No. 100980-86-7

Benzoic acid, 4-(propoxymethyl)-, 4-cyano-3-fluorophenyl ester

Catalog No.:AG0003CW MDL No.:

MF:C18H16FNO3 MW:313.3229

CAS No. 100980-98-1

2-Propenoic acid, 3-[4-(2-phenylethenyl)phenyl]-, hydrazide

Catalog No.:AG0003CV MDL No.:

MF:C17H16N2O MW:264.3217

CAS No. 100981-05-3

1,3-Dioxane-4,6-dione, 5-[bis(methylthio)methylene]-2,2-dimethyl-

Catalog No.:AG0003CU MDL No.:MFCD00107207

MF:C9H12O4S2 MW:248.3192

CAS No. 100981-08-6

1,3-Dioxane-4,6-dione, 5-[bis(ethylthio)methylene]-2,2-dimethyl-

Catalog No.:AG0003CT MDL No.:

MF:C11H16O4S2 MW:276.3723

CAS No. 1009811-89-5

6-Quinolinol, 3-bromo-7-chloro-

Catalog No.:AG0003CN MDL No.:

MF:C9H5BrClNO MW:258.4991

CAS No. 1009817-63-3

4-Piperidinone, 3,5-bis[(4-nitrophenyl)methylene]-1-(1-oxo-2-propen-1-yl)-, (3E,5E)-

Catalog No.:AG0003CL MDL No.:MFCD26142662

MF:C22H17N3O6 MW:419.3869

CAS No. 1009818-70-5

1H-Indole-3-carboxylic acid, 4-chloro-, ethyl ester

Catalog No.:AG0003CK MDL No.:MFCD11617103

MF:C11H10ClNO2 MW:223.6556

CAS No. 1009821-06-0

5-((3-Ethynylphenyl)amino)pyrimido[4,5-c]quinoline-8-carboxylic acid

Catalog No.:AG0003DD MDL No.:MFCD11977745

MF:C20H12N4O2 MW:340.3349

CAS No. 1009826-93-0

4-Pyrimidinecarboxylic acid, 5-bromo-, methyl ester

Catalog No.:AG0003DC MDL No.:MFCD11111841

MF:C6H5BrN2O2 MW:217.0201

CAS No. 100983-10-6

Propanoic acid, 3-bromo-, 1-methylethyl ester

Catalog No.:AG0003DV MDL No.:

MF:C6H11BrO2 MW:195.0543

CAS No. 100983-91-3

Ethanol, 2-[[5-amino-2-[(2-hydroxyethyl)amino]phenyl]sulfonyl]-

Catalog No.:AG0003DU MDL No.:

MF:C10H16N2O4S MW:260.3100

CAS No. 100983-99-1

Ethanol, 2-[[2-[(2-hydroxyethyl)sulfonyl]-4-nitrophenyl]thio]-

Catalog No.:AG0003DT MDL No.:

MF:C10H13NO6S2 MW:307.3433

CAS No. 1009838-57-6

1H-Pyrrolo[2,3-b]pyridine-3-carbonitrile, 4-(2,4-dichlorophenyl)-

Catalog No.:AG0003DB MDL No.:

MF:C14H7Cl2N3 MW:288.1315

CAS No. 1009838-58-7

1H-Pyrrolo[2,3-b]pyridine-3-carbonitrile, 6-chloro-4-(2,4-dichlorophenyl)-

Catalog No.:AG0003DA MDL No.:

MF:C14H6Cl3N3 MW:322.5765

CAS No. 1009838-81-6

1H-Pyrrolo[2,3-b]pyridine-3-carbonitrile, 4-iodo-

Catalog No.:AG0003D9 MDL No.:

MF:C8H4IN3 MW:269.0419

CAS No. 100984-01-8

1-Propanol, 3-[[4-amino-2-[(2-hydroxyethyl)sulfonyl]phenyl]amino]-

Catalog No.:AG0003DS MDL No.:

MF:C11H18N2O4S MW:274.3366

CAS No. 100984-03-0

2-Propanol, 1-[[4-amino-2-[(2-hydroxyethyl)sulfonyl]phenyl]amino]-

Catalog No.:AG0003DR MDL No.:

MF:C11H18N2O4S MW:274.3366

CAS No. 1009842-68-5

Quinoline, 5-chloro-8-(phenylMethoxy)-7-(2-propen-1-yl)-

Catalog No.:AG0003D8 MDL No.:

MF:C19H16ClNO MW:309.7894

CAS No. 100986-86-5

7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (3R)-

Catalog No.:AG0003DP MDL No.:MFCD00869643

MF:C18H20FN3O4 MW:361.3675

CAS No. 100986-89-8

7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9,10-difluoro-2,3-dihydro-3-methyl-7-oxo-, (3S)-

Catalog No.:AG0003DO MDL No.:MFCD04039905

MF:C13H9F2NO4 MW:281.2117

CAS No. 100987-04-0

1,3,4-Thiadiazol-2-amine, 5-[4-(1,1-dimethylethyl)phenyl]-

Catalog No.:AG0003DN MDL No.:MFCD00980739

MF:C12H15N3S MW:233.3326

CAS No. 100987-89-1

1,3,4-Thiadiazol-2-amine, 5-[4-(1-methylethyl)phenyl]-

Catalog No.:AG0003DM MDL No.:MFCD02032690

MF:C11H13N3S MW:219.3060

CAS No. 100988-63-4

Pyridinium, 1-[[(6R,7R)-7-amino-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-, iodide (1:1)

Catalog No.:AG0003DL MDL No.:

MF:C13H14IN3O3S MW:419.2380

CAS No. 100989-42-2

1,4-Pentanedione, 3-acetyl-1-(4-chlorophenyl)-

Catalog No.:AG0003DK MDL No.:

MF:C13H13ClO3 MW:252.6935

CAS No. 100989-43-3

Ethanone, 1-[5-(4-chlorophenyl)-2-methyl-1-phenyl-1H-pyrrol-3-yl]-

Catalog No.:AG0003DJ MDL No.:

MF:C19H16ClNO MW:309.7894

CAS No. 100989-61-5

Ethanone, 1-[2-methyl-5-(3-nitrophenyl)-1-phenyl-1H-pyrrol-3-yl]-

Catalog No.:AG0003DI MDL No.:

MF:C19H16N2O3 MW:320.3419

CAS No. 100989-78-4

2-Decanethiol, 2-methyl-

Catalog No.:AG0003DH MDL No.:

MF:C11H24S MW:188.3733

CAS No. 100989-88-6

2-Butanone, 3-methyl-3-[(2-oxo-2-phenylethyl)thio]-

Catalog No.:AG0003DG MDL No.:

MF:C13H16O2S MW:236.3299

CAS No. 100989-94-4

Thiophene, 2,5-dihydro-3,4-diphenyl-

Catalog No.:AG0003DF MDL No.:

MF:C16H14S MW:238.3474

CAS No. 100989-95-5

Thiophene, 2,5-dihydro-3,4-di-2-naphthalenyl-

Catalog No.:AG0003DE MDL No.:

MF:C24H18S MW:338.4647

CAS No. 10099-01-1

Thietane, 3,3-bis(2-methylpropoxy)-2-phenyl-, 1,1-dioxide

Catalog No.:AG0003DW MDL No.:

MF:C17H26O4S MW:326.4509

CAS No. 10099-04-4

Thietane, 3,3-bis(2-methylpropoxy)-, 1,1-dioxide

Catalog No.:AG0003EL MDL No.:

MF:C11H22O4S MW:250.3550

CAS No. 10099-13-5

2H-Thiopyran-3(6H)-one, 5-ethoxy-, 1,1-dioxide

Catalog No.:AG0003EK MDL No.:

MF:C7H10O4S MW:190.2169

CAS No. 10099-19-1

Piperidine, 1,1'-[(benzylsulfonyl)vinylidene]di- (8CI)

Catalog No.:AG0003EJ MDL No.:

MF:C19H28N2O2S MW:348.5028

CAS No. 10099-20-4

Piperidine, 1,1'-[bis(benzylsulfonyl)vinylidene]di- (8CI)

Catalog No.:AG0003EI MDL No.:

MF:C26H34N2O4S2 MW:502.6892

CAS No. 10099-21-5

Piperidine, 1,1'-[(benzylsulfonyl)(methylsulfonyl)vinylidene]di- (8CI)

Catalog No.:AG0003EH MDL No.:

MF:C20H30N2O4S2 MW:426.5932

CAS No. 10099-57-7

Benzeneethanol, 4-(1-methylethyl)-

Catalog No.:AG0003EG MDL No.:

MF:C11H16O MW:164.2441

CAS No. 10099-70-4

2-Butenedioic acid (2Z)-, 1,4-bis(1-methylethyl) ester

Catalog No.:AG0003EB MDL No.:

MF:C10H16O4 MW:200.2316

CAS No. 10099-71-5

2-Butenedioic acid (2Z)-, 1,4-dipentyl ester

Catalog No.:AG0003EA MDL No.:

MF:C14H24O4 MW:256.3380

CAS No. 10099-73-7

2-Butenedioic acid (2Z)-, 1-(2-hydroxypropyl) ester

Catalog No.:AG0003E9 MDL No.:

MF:C7H10O5 MW:174.1513

CAS No. 10099-79-3

Lead vanadium oxide (PbV2O6)

Catalog No.:AG0003E6 MDL No.:MFCD00016271

MF: MW:

CAS No. 100990-01-0

Thiophene, 3,4-bis(4-bromophenyl)-2,5-dihydro-

Catalog No.:AG0003E5 MDL No.:

MF:C16H12Br2S MW:396.1395

CAS No. 100990-57-6

Benzamide, N-[4-(1-methylethyl)phenyl]-

Catalog No.:AG0003E4 MDL No.:

MF:C16H17NO MW:239.3123

CAS No. 100991-09-1

5-Pyrimidinol, 2-(trifluoromethyl)-

Catalog No.:AG0003E3 MDL No.:MFCD10696944

MF:C5H3F3N2O MW:164.0853

CAS No. 100991-12-6

Pyrimidine, 5-(phenylmethoxy)-2-(trifluoromethyl)-

Catalog No.:AG0003E2 MDL No.:

MF:C12H9F3N2O MW:254.2079

CAS No. 100991-27-3

9-Dodecyn-2-ol, 12-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-

Catalog No.:AG0003E1 MDL No.:

MF:C18H36O2Si MW:312.5627

CAS No. 100991-59-1

4-Morpholinecarbothioic acid, O-(2,3,4,5,6-pentachlorophenyl) ester

Catalog No.:AG0003E0 MDL No.:

MF:C11H8Cl5NO2S MW:395.5167

CAS No. 100991-60-4

1H-Indene-1-thione, 2,3-dihydro-2,2-dimethyl-

Catalog No.:AG0003DZ MDL No.:

MF:C11H12S MW:176.2780

CAS No. 100991-62-6

1-Propanethione, 1-(2-furanyl)-2,2-dimethyl-

Catalog No.:AG0003DY MDL No.:

MF:C9H12OS MW:168.2560

CAS No. 100991-90-0

Carbamic acid, (3,4-dichlorophenyl)-, monoester with 4,4,4-trifluoro-1-(4-fluorophenyl)-2-methyl-3-(trifluoromethyl)-1,3-butanediol (9CI)

Catalog No.:AG0003DX MDL No.:

MF:C19H14Cl2F7NO3 MW:508.2142

CAS No. 100991-94-4

L-Asparagine, N-[2-(acetylamino)-2-deoxy-D-galactopyranosyl]-

Catalog No.:AG0003EV MDL No.:

MF:C12H21N3O8 MW:335.3104

CAS No. 100992-59-4

L-Aspartic acid, N-[(2R,3R)-3-amino-2-hydroxy-5-methyl-1-oxohexyl]-L-valyl-L-valyl-, monohydrochloride (9CI)

Catalog No.:AG0003EU MDL No.:

MF:C21H39ClN4O8 MW:511.0094

CAS No. 100992-60-7

L-Leucine, N-[(2R,3R)-3-amino-2-hydroxy-1-oxo-4-phenylbutyl]-, hydrochloride (1:1)

Catalog No.:AG0003ET MDL No.:

MF:C16H25ClN2O4 MW:344.8337

CAS No. 100993-02-0

Bicyclo[2.2.1]heptan-2-ol, 1,7,7-trimethyl-2-(2-pyridinyl)-, (1R,2R,4R)-

Catalog No.:AG0003ES MDL No.:

MF:C15H21NO MW:231.3333

CAS No. 100993-68-8

Phosphorodiamidic acid, N,N-bis(2-chloroethyl)-, 3-oxo-3-phenylpropyl ester

Catalog No.:AG0003ER MDL No.:

MF:C13H19Cl2N2O3P MW:353.1813

CAS No. 100997-48-6

1H-Indole-2,3-dicarboxylic acid, 7-formyl-4,6-dimethoxy-, 2,3-dimethyl ester

Catalog No.:AG0003EQ MDL No.:

MF:C15H15NO7 MW:321.2821

CAS No. 100997-64-6

Cytidine, N-methyl-N-(methylamino)- (9CI)

Catalog No.:AG0003EP MDL No.:

MF:C11H18N4O5 MW:286.2844

CAS No. 100997-66-8

2(1H)-Pyrimidinone, 4-[1-(2-hydroxyethyl)hydrazino]-1-β-D-ribofuranosyl- (9CI)

Catalog No.:AG0003EO MDL No.:

MF:C11H18N4O6 MW:302.2838

CAS No. 100997-68-0

2(1H)-Pyrimidinone, 4-(1-methylhydrazino)-1-β-D-ribofuranosyl- (9CI)

Catalog No.:AG0003EN MDL No.:

MF:C10H16N4O5 MW:272.2578

CAS No. 100997-70-4

Benzamide, 2,6-difluoro-N-[[[4-(2-pyridinyloxy)phenyl]amino]carbonyl]-

Catalog No.:AG0003EM MDL No.:

MF:C19H13F2N3O3 MW:369.3216

CAS No. 101-00-8

2,8,9-Trioxa-5-aza-1-borabicyclo[3.3.3]undecane, 3,7,10-trimethyl-

Catalog No.:AG0003F7 MDL No.:MFCD03791298

MF:C9H18BNO3 MW:199.0551

CAS No. 101-01-9

Guanidine, N,N',N''-triphenyl-

Catalog No.:AG0003F6 MDL No.:MFCD00020648

MF:C19H17N3 MW:287.3584

CAS No. 101-06-4

Ethanol, 2-[bis(phenylmethyl)amino]-

Catalog No.:AG0003F4 MDL No.:MFCD00020574

MF:C16H19NO MW:241.3282

CAS No. 101-07-5

Ethanol, 2-[bis(2-ethylhexyl)amino]-

Catalog No.:AG0003F3 MDL No.:

MF:C18H39NO MW:285.5084

CAS No. 101-09-7

Acetic acid, 2-[(3-aminophenyl)amino]-2-oxo-

Catalog No.:AG0003F2 MDL No.:

MF:C8H8N2O3 MW:180.1607

CAS No. 101-11-1

Benzenesulfonic acid, 3-[(ethylphenylamino)methyl]-

Catalog No.:AG0003F0 MDL No.:MFCD00035761

MF:C15H17NO3S MW:291.3654

CAS No. 101-12-2

Benzamide, 3-amino-N-(3-aminophenyl)-

Catalog No.:AG0003EZ MDL No.:

MF:C13H13N3O MW:227.2618

CAS No. 101-13-3

Benzenamine, 3,3'-(1-oxido-1,2-diazenediyl)bis-

Catalog No.:AG0003EY MDL No.:

MF: MW:

CAS No. 101-15-5

2,5-Cyclohexadien-1-one, 4-[(4-amino-3-methylphenyl)imino]-

Catalog No.:AG0003EX MDL No.:

MF:C13H12N2O MW:212.2472

CAS No. 101-16-6

Benzenamine, 3-methoxy-N-phenyl-

Catalog No.:AG0003EW MDL No.:MFCD00008383

MF:C13H13NO MW:199.2484

CAS No. 101-17-7

Benzenamine, 3-chloro-N-phenyl-

Catalog No.:AG0003FQ MDL No.:MFCD00000590

MF:C12H10ClN MW:203.6675

CAS No. 101-18-8

Phenol, 3-(phenylamino)-

Catalog No.:AG0003FP MDL No.:MFCD00002262

MF:C12H11NO MW:185.2218

CAS No. 101-20-2

Urea, N-(4-chlorophenyl)-N'-(3,4-dichlorophenyl)-

Catalog No.:AG0003FO MDL No.:MFCD00013254

MF:C13H9Cl3N2O MW:315.5824

CAS No. 101-22-4

Urea, N,N'-bis(3-aminophenyl)-

Catalog No.:AG0003FN MDL No.:

MF:C13H14N4O MW:242.2765

CAS No. 101-23-5

Benzenamine, N-phenyl-3-(trifluoromethyl)-

Catalog No.:AG0003FM MDL No.:MFCD00017998

MF:C13H10F3N MW:237.2204

CAS No. 101-29-1

1(4H)-Pyridineacetic acid, 3,5-diiodo-4-oxo-

Catalog No.:AG0003FK MDL No.:MFCD00006185

MF:C7H5I2NO3 MW:404.9284

CAS No. 101-31-5

Benzeneacetic acid, α-(hydroxymethyl)-, (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, (αS)-

Catalog No.:AG0003FJ MDL No.:MFCD00067306

MF:C17H23NO3 MW:289.3694

CAS No. 101-32-6

Ethanol, 2,2'-[(phenylmethyl)imino]bis-

Catalog No.:AG0003FI MDL No.:MFCD00020587

MF:C11H17NO2 MW:195.2582

CAS No. 101-33-7

Hexane, 1,1,3-triethoxy-

Catalog No.:AG0003FH MDL No.:

MF:C12H26O3 MW:218.3330

CAS No. 101-36-0

Boroxin, 2,4,6-tributoxy-

Catalog No.:AG0003FG MDL No.:

MF:C12H27B3O6 MW:299.7722

CAS No. 101-39-3

2-Propenal, 2-methyl-3-phenyl-

Catalog No.:AG0003FF MDL No.:MFCD00006976

MF:C10H10O MW:146.1858

CAS No. 101-43-9

2-Propenoic acid, 2-methyl-, cyclohexyl ester

Catalog No.:AG0003FC MDL No.:MFCD00014292

MF:C10H16O2 MW:168.2328

CAS No. 101-45-1

Ethanol, 2-[(1-methyl-2-phenoxyethyl)(phenylmethyl)amino]-

Catalog No.:AG0003FB MDL No.:

MF:C18H23NO2 MW:285.3807

CAS No. 101-48-4

Benzene, (2,2-dimethoxyethyl)-

Catalog No.:AG0003FA MDL No.:MFCD00008487

MF:C10H14O2 MW:166.2170

CAS No. 101-49-5

1,3-Dioxolane, 2-(phenylmethyl)-

Catalog No.:AG0003F9 MDL No.:MFCD00003215

MF:C10H12O2 MW:164.2011

CAS No. 101-52-0

Benzenamine, 2-methoxy-4-[2-(4-nitrophenyl)diazenyl]-

Catalog No.:AG0003F8 MDL No.:

MF:C13H12N4O3 MW:272.2594

CAS No. 101-53-1

Phenol, 4-(phenylmethyl)-

Catalog No.:AG0003G8 MDL No.:MFCD00002384

MF:C13H12O MW:184.2338

CAS No. 101-55-3

Benzene, 1-bromo-4-phenoxy-

Catalog No.:AG0003G7 MDL No.:MFCD00000094

MF:C12H9BrO MW:249.1033

CAS No. 101-56-4

Benzenediazonium, 4-(phenylamino)-, chloride (1:1)

Catalog No.:AG0003G6 MDL No.:

MF:C12H10ClN3 MW:231.6809

CAS No. 101-58-6

Benzene, 1,1'-oxybis[4-(1,1,3,3-tetramethylbutyl)- (9CI)

Catalog No.:AG0003G5 MDL No.:

MF:C28H42O MW:394.6325

CAS No. 101-59-7

Benzenamine, 4-[(4-nitrophenyl)thio]-

Catalog No.:AG0003G4 MDL No.:MFCD00007881

MF:C12H10N2O2S MW:246.2850

CAS No. 101-60-0

21H,23H-Porphine

Catalog No.:AG0003G3 MDL No.:

MF:C20H14N4 MW:310.3520

CAS No. 101-63-3

Benzene, 1,1'-oxybis[4-nitro-

Catalog No.:AG0003G2 MDL No.:MFCD00059182

MF:C12H8N2O5 MW:260.2023

CAS No. 101-67-7

Benzenamine, 4-octyl-N-(4-octylphenyl)-

Catalog No.:AG0003G1 MDL No.:MFCD00048942

MF:C28H43N MW:393.6477

CAS No. 101-70-2

Benzenamine, 4-methoxy-N-(4-methoxyphenyl)-

Catalog No.:AG0003FZ MDL No.:MFCD00014895

MF:C14H15NO2 MW:229.2744

CAS No. 101-74-6

Phenol, 4-[[4-(phenylamino)phenyl]amino]-

Catalog No.:AG0003FY MDL No.:

MF:C18H16N2O MW:276.3324

CAS No. 101-75-7

Benzenamine, N-phenyl-4-(2-phenyldiazenyl)-

Catalog No.:AG0003FX MDL No.:MFCD00003023

MF:C18H15N3 MW:273.3318

CAS No. 101-79-1

Benzenamine, 4-(4-chlorophenoxy)-

Catalog No.:AG0003FW MDL No.:MFCD00043925

MF:C12H10ClNO MW:219.6669

CAS No. 101-81-5

Benzene, 1,1'-methylenebis-

Catalog No.:AG0003FV MDL No.:MFCD00004781

MF:C13H12 MW:168.2344

CAS No. 101-84-8

Benzene, 1,1'-oxybis-

Catalog No.:AG0003FS MDL No.:MFCD00003034

MF:C12H10O MW:170.2072

CAS No. 101-85-9

1-Heptanol, 2-(phenylmethylene)-

Catalog No.:AG0003FR MDL No.:MFCD00022004

MF:C14H20O MW:204.3080

CAS No. 101-86-0

Octanal, 2-(phenylmethylene)-

Catalog No.:AG0003GV MDL No.:MFCD00006989

MF:C15H20O MW:216.3187

CAS No. 101-89-3

Benzenediazonium, 2-methyl-4-[2-(2-methylphenyl)diazenyl]-, sulfate (1:1)

Catalog No.:AG0003GU MDL No.:MFCD00011883

MF:C14H14N4O4S MW:334.3504

CAS No. 101-90-6

Oxirane, 2,2'-[1,3-phenylenebis(oxymethylene)]bis-

Catalog No.:AG0003GT MDL No.:MFCD00078378

MF:C12H14O4 MW:222.2372

CAS No. 101-91-7

Butanamide, N-(4-hydroxyphenyl)-

Catalog No.:AG0003GS MDL No.:

MF:C10H13NO2 MW:179.2157

CAS No. 101-92-8

Butanamide, N-(4-chlorophenyl)-3-oxo-

Catalog No.:AG0003GR MDL No.:MFCD00000613

MF:C10H10ClNO2 MW:211.6449

CAS No. 101-94-0

Benzeneacetic acid, 4-methylphenyl ester

Catalog No.:AG0003GQ MDL No.:MFCD00025983

MF:C15H14O2 MW:226.2705

CAS No. 101-98-4

Ethanol, 2-[methyl(phenylmethyl)amino]-

Catalog No.:AG0003GO MDL No.:MFCD00002847

MF:C10H15NO MW:165.2322

CAS No. 101-99-5

Carbamic acid, N-phenyl-, ethyl ester

Catalog No.:AG0003GN MDL No.:MFCD00026806

MF:C9H11NO2 MW:165.1891

CAS No. 1010-19-1

Benzenaminium, N,N,N-triethyl-, iodide (1:1)

Catalog No.:AG0003GM MDL No.:MFCD00050224

MF:C12H20IN MW:305.1984

CAS No. 1010-26-0

3-Oxaspiro[5.5]undecane-2,4-dione

Catalog No.:AG0003GL MDL No.:MFCD00040292

MF:C10H14O3 MW:182.2164

CAS No. 1010-33-9

1,4-Dioxaspiro[4.8]tridecane

Catalog No.:AG0003GK MDL No.:

MF:C11H20O2 MW:184.2753

CAS No. 1010-38-4

Phosphonic acid, P-[2-(1-aziridinyl)ethyl]-, diethyl ester

Catalog No.:AG0003GJ MDL No.:

MF:C8H18NO3P MW:207.2072

CAS No. 1010-48-6

Benzenepropanoic acid, β,β-dimethyl-

Catalog No.:AG0003GI MDL No.:MFCD00020492

MF:C11H14O2 MW:178.2277

CAS No. 1010-50-0

Benzo[b]thiophene, 2,3,4,7-tetramethyl-

Catalog No.:AG0003GH MDL No.:

MF:C12H14S MW:190.3046

CAS No. 1010-53-3

2,4-Thiazolidinedione, 3-phenyl-

Catalog No.:AG0003GG MDL No.:MFCD00094227

MF:C9H7NO2S MW:193.2224

CAS No. 1010-54-4

3H-1,2,4-Triazol-3-one, 2,4-dihydro-5-methyl-4-phenyl-

Catalog No.:AG0003GF MDL No.:MFCD03787260

MF:C9H9N3O MW:175.1873

CAS No. 1010-55-5

4-Pteridinamine, 7-methyl-, 5-oxide

Catalog No.:AG0003GE MDL No.:

MF:C7H7N5O MW:177.1634

CAS No. 1010-56-6

1,3-Cyclohexanedione, 2-(1-aminoethylidene)-5,5-dimethyl-

Catalog No.:AG0003GD MDL No.:

MF:C10H15NO2 MW:181.2316

CAS No. 1010-59-9

1H-Purine-2,6-dione, 3,7-dihydro-3,7-dimethyl-, sodium salt (1:1)

Catalog No.:AG0003GC MDL No.:

MF:C7H8N4NaO2 MW:203.1538

CAS No. 1010-60-2

1,4-Naphthalenedione, 2-chloro-

Catalog No.:AG0003GB MDL No.:MFCD00029187

MF:C10H5ClO2 MW:192.5985

CAS No. 1010-68-0

2H-Indol-2-one, 1,3-dihydro-5-hydroxy-1,3-dimethyl-

Catalog No.:AG0003GA MDL No.:

MF:C10H11NO2 MW:177.1998

CAS No. 1010-77-1

Dibenzofuran, 1,2,3,4,6,7,8,9-octahydro-

Catalog No.:AG0003G9 MDL No.:

MF:C12H16O MW:176.2548

CAS No. 1010-78-2

Pyrido[2',3':3,4]pyrazolo[1,5-a]pyrimidine (8CI,9CI)

Catalog No.:AG0003HK MDL No.:

MF:C9H6N4 MW:170.1707

CAS No. 1010-82-8

5(1H)-Quinolinone, 2,3,4,6,7,8-hexahydro-7,7-dimethyl-

Catalog No.:AG0003HJ MDL No.:

MF:C11H17NO MW:179.2588

CAS No. 1010-90-8

2,4(1H,3H)-Pyrimidinedione, 3-butyl-6-methyl-

Catalog No.:AG0003HI MDL No.:

MF:C9H14N2O2 MW:182.2197

CAS No. 1010-93-1

1H-Imidazole-1-acetic acid, 2-methyl-5-nitro-

Catalog No.:AG0003HH MDL No.:MFCD01721819

MF:C6H7N3O4 MW:185.1375

CAS No. 1010-95-3

1H-Indole-3-ethanamine, 5-methyl-, hydrochloride (1:1)

Catalog No.:AG0003HG MDL No.:MFCD00012683

MF:C11H15ClN2 MW:210.7032

CAS No. 1010-99-7

1,2-Benzenediol, 3-(1,1-dimethylethyl)-5-methyl-

Catalog No.:AG0003HF MDL No.:

MF:C11H16O2 MW:180.2435

CAS No. 10100-93-3

Hexaneperoxoic acid, 6-bromo-, 1,1-dimethylethyl ester

Catalog No.:AG0003HE MDL No.:

MF:C10H19BrO3 MW:267.1601

CAS No. 10100-94-4

Hexaneperoxoic acid, 1,1-dimethylethyl ester

Catalog No.:AG0003HD MDL No.:

MF:C10H20O3 MW:188.2640

CAS No. 10100-95-5

Pentane, 1-(1,1-dimethylethoxy)-

Catalog No.:AG0003HC MDL No.:

MF:C9H20O MW:144.2545

CAS No. 101000-49-1

Propanamide, N-[(8α)-2-chloro-6-methylergolin-8-yl]-2,2-dimethyl-

Catalog No.:AG0003HB MDL No.:

MF:C20H26ClN3O MW:359.8929

CAS No. 101000-95-7

Benzo[b]thiophen-3(2H)-one, 2-[(4-methoxyphenyl)methylene]-, (2Z)-

Catalog No.:AG0003HA MDL No.:

MF:C16H12O2S MW:268.3303

CAS No. 101001-37-0

1H-Pyrrole-1-acetic acid, 2-[4,5-bis(4-methoxyphenyl)-2-thiazolyl]-, butyl ester

Catalog No.:AG0003H9 MDL No.:

MF:C27H28N2O4S MW:476.5872

CAS No. 101001-50-7

1H-Pyrrole-1-acetic acid, 2-[4,5-bis(4-methoxyphenyl)-2-thiazolyl]-, 2-propyn-1-yl ester

Catalog No.:AG0003H8 MDL No.:

MF:C26H22N2O4S MW:458.5289

CAS No. 101001-51-8

1H-Pyrrole-1-acetic acid, 2-[4,5-bis(4-methoxyphenyl)-2-thiazolyl]-, phenylmethyl ester

Catalog No.:AG0003H7 MDL No.:

MF:C30H26N2O4S MW:510.6034

CAS No. 101001-68-7

1H-Pyrrole-2-carboxaldehyde, 1-(2-propen-1-yl)-

Catalog No.:AG0003H6 MDL No.:MFCD11505317

MF:C8H9NO MW:135.1632

CAS No. 101001-72-3

1H-Pyrrole-1-acetic acid, 2-[4,5-bis(4-methoxyphenyl)-2-thiazolyl]-

Catalog No.:AG0003H5 MDL No.:

MF:C23H20N2O4S MW:420.4809

CAS No. 101001-73-4

Acetic acid, 2-bromo-, 2,2-dimethylpropyl ester

Catalog No.:AG0003H4 MDL No.:

MF:C7H13BrO2 MW:209.0809

CAS No. 101001-79-0

1,2,4-Triazolo[4,3-a]pyridine, 5-(2-pyridinyl)-

Catalog No.:AG0003H3 MDL No.:

MF:C11H8N4 MW:196.2080

CAS No. 101001-90-5

[2,2'-Bipyridin]-6(1H)-one

Catalog No.:AG0003H2 MDL No.:

MF:C10H8N2O MW:172.1833

CAS No. 101002-15-7

Ethanone, 1-[2-hydroxy-4-(pentyloxy)phenyl]-, oxime

Catalog No.:AG0003H1 MDL No.:

MF:C13H19NO3 MW:237.2949

CAS No. 101002-18-0

Ethanone, 1-(4-butoxy-5-hexyl-2-hydroxyphenyl)-, oxime

Catalog No.:AG0003H0 MDL No.:

MF:C18H29NO3 MW:307.4278

CAS No. 101002-20-4

1-Hexanone, 1-[4-(decyloxy)-2-hydroxyphenyl]-, oxime

Catalog No.:AG0003GZ MDL No.:

MF:C22H37NO3 MW:363.5341

CAS No. 101002-36-2

Stannane, bis[[(4-methylphenyl)sulfonyl]oxy]dipropyl- (9CI)

Catalog No.:AG0003GY MDL No.:

MF:C20H28O6S2Sn MW:547.2637

CAS No. 101002-44-2

[1,1'-Biphenyl]-4-carboxaldehyde, 4'-ethyl-

Catalog No.:AG0003GX MDL No.:

MF:C15H14O MW:210.2711

CAS No. 101002-46-4

4H-1-Benzopyran-8-acetic acid, 2-(4-chlorophenyl)-4-oxo-

Catalog No.:AG0003GW MDL No.:

MF:C17H11ClO4 MW:314.7198

CAS No. 1010068-13-9

Thieno[2,3-d]pyrimidin-4(1H)-one, 2-amino-

Catalog No.:AG0003HV MDL No.:

MF:C6H5N3OS MW:167.1884

CAS No. 1010068-85-5

Boronic acid, B-(6-phenyl-4-dibenzofuranyl)-

Catalog No.:AG0003HU MDL No.:MFCD29077673

MF:C18H13BO3 MW:288.1050

CAS No. 1010072-35-1

2-Benzofurancarboxylic acid, 7-bromo-5-nitro-, ethyl ester

Catalog No.:AG0003HT MDL No.:MFCD11112161

MF:C11H8BrNO5 MW:314.0889

CAS No. 1010073-87-6

1H-Pyrazolo[3,4-b]pyridine-3-carboxaldehyde

Catalog No.:AG0003HS MDL No.:MFCD11100578

MF:C7H5N3O MW:147.1341

CAS No. 1010086-31-3

Cyclohexanecarboxylic acid, 4-[[(1,1-dimethylethyl)diphenylsilyl]oxy]-, 1,1-dimethylethyl ester

Catalog No.:AG0003HR MDL No.:MFCD17392810

MF:C27H38O3Si MW:438.6743

CAS No. 1010086-61-9

2-PyrazinaMine, 6-chloro-N-[1-(1,1-diMethylethyl)-1H-pyrazol-5-yl]-

Catalog No.:AG0003HQ MDL No.:

MF:C11H14ClN5 MW:251.7154

CAS No. 1010086-67-5

2-PyrazineMethanol, 6-[[1-(1,1-diMethylethyl)-1H-pyrazol-5-yl]aMino]-

Catalog No.:AG0003HP MDL No.:MFCD26383549

MF:C12H17N5O MW:247.2963

CAS No. 1010090-00-2

1-Piperidinecarboxylic acid, 3-[[(2-methoxyphenyl)sulfonyl]amino]-, 1,1-dimethylethyl ester, (3S)-

Catalog No.:AG0003HO MDL No.:

MF:C17H26N2O5S MW:370.4637

CAS No. 1010090-02-4

1-Piperidinecarboxylic acid, 3-[[(2-methoxyphenyl)sulfonyl]amino]-, 1,1-dimethylethyl ester, (3R)-

Catalog No.:AG0003HN MDL No.:

MF:C17H26N2O5S MW:370.4637

CAS No. 1010097-71-8

Boronic acid, B-(2-ethoxy-3-fluorophenyl)-

Catalog No.:AG0003HM MDL No.:MFCD11520053

MF:C8H10BFO3 MW:183.9726

CAS No. 1010097-72-9

Boronic acid, B-(3-fluoro-2-propoxyphenyl)-

Catalog No.:AG0003HL MDL No.:

MF:C9H12BFO3 MW:197.9992

© 2019 Angene International Limited. All rights Reserved.